Alcohol Use Disorders & Co-Occurring Mental Health Disorders
Primary care physicians, nurses, mental health professionals, substance use disorder professionals, or any clinic staff who support behavioral health services.
Case presentations are truly the core of every ECHO session. During each ECHO session each participant who chooses to present will gain access to unique feedback and questions from a wide range of peers and experts in an all-teach, all-learn modality. The ECHO session facilitator will moderate the case presentation and discussion portion of every session to ensure all participants have a change to engage in the peer-to-peer learning.
The Behavioral Health ECHO program supports primary care providers in the assessment and management of substance use and mental health disorders. The learning series will utilize the ECHO Model to train and support primary care team members, behavioral health professionals and case managers in treatment and management of substance use disorders, psychiatric illnesses and associated co-morbidities, with the goal to help enhance integrated care in identifying and treating these concerns in their patients.
This will be done by disseminating evidence based best practice care to improve patient outcomes in the form of didactic instruction as well as case discussions to enhance learning and improving quality of care opportunities.
Iowa is designated as a Health Professional Shortage Area especially for treatment and management of behavioral health disorders. The Behavioral Health ECHO learning series will utilize the ECHO Model to train and support primary care team members, behavioral health professionals and case managers in treatment and management of substance use disorders, psychiatric illnesses and associated co-morbidities, with the goal to help enhance integrated care in identifying and treating these concerns in their patients. This will be done by disseminating evidence based best practice care to improve patient outcomes in the form of didactic instruction as well as the feedback provided by the hub team experts and peers during case discussions will enhance quality of care and consequently patient health outcomes.
- Restate the diagnostic criteria for Alcohol Use Disorders.
- Identify concurrent Substance Use and Alcohol Use Disorders.
- Describe pharmacological agents for the maintenance treatment of Alcohol Use Disorders.
Nicole Gastala, MD
Primary Health Care, Lead Physician
Andrea Storjohann, ARNP
Primary Health Care, MAT Program Manager
Gagandeep Lamba, MA, MS, MBA
Iowa Primary Care Association
Iowa Primary Care Association
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University (DMU) and the Iowa Primary Care Association. DMU is accredited by IMS to provide continuing medical education for physicians. DMU designates this live, online activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 1.5 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This live activity has been reviewed and approved for 1.5 continuing education contact hour(s). No partial credit awarded.
- Other Healthcare Professionals: This live activity is designated for a maximum of 1.5 AMA PRA Category 1 Credit(s)™.
No commercial interest company provided financial support for this continuing education activity.
Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with commercial interest companies to disclose.
- Julie Baker, MPA, CHCEF, Planning Committee Member
- Bery Engebretsen, MD, Planning Committee Member
- Nicolas Foss, MS, IADC, BACC, ICGC-II, Planning Committee Member
- Gagandeep Lamba, MA, MS, MBA, Activity Director/Coordinator and Planning Committee Member
- Elizabeth Noble, Activity Coordinator
- Danielle O'Brien-Day, LMHC, CRC, Planning Committee Member
- Nicole Gastala, MD, Planning Committee Member and Speaker
- Andrea Storjohann, MSN, ARNP, PMHNP-BC, CADC, Planning Committee Member and Speaker
Relevant to the content of this educational activity, the following individual(s) have a conflict(s) with commercial interest companies to disclose.
- Janice Landy, MD, Planning Committee Member and Speaker - Does not have a conflict with a commercial interest company; however, does intend to discuss off-label uses of commercial products.
The speaker(s) will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director.
The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.
- 1.50 AMA PRA Category 1 Credits™
- 1.50 AOA Category 2A
- 1.50 CE Contact Hour(s)
- 1.50 IBON